Clinical Trial Update: A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin. [Phase 2]

View source ↗

Summary

Roche completed a Phase 2 trial evaluating a GLP-1 analogue (taspoglutide) in patients with Type 2 diabetes mellitus treated with metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Taspoglutide (taspoglutide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED